Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) EBT (2020 - 2025)

Historic EBT for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to -$10.1 million.

  • Cresco Labs' EBT fell 18921.57% to -$10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year decrease of 51207.5%. This contributed to the annual value of -$10.6 million for FY2024, which is 9277.34% up from last year.
  • Latest data reveals that Cresco Labs reported EBT of -$10.1 million as of Q3 2025, which was down 18921.57% from $2.7 million recorded in Q2 2025.
  • Cresco Labs' 5-year EBT high stood at $16.1 million for Q2 2021, and its period low was -$275.9 million during Q3 2021.
  • Moreover, its 5-year median value for EBT was -$868000.0 (2022), whereas its average is -$28.9 million.
  • In the last 5 years, Cresco Labs' EBT plummeted by 185875.04% in 2021 and then soared by 24494.23% in 2024.
  • Cresco Labs' EBT (Quarter) stood at $11.6 million in 2021, then crashed by 1450.28% to -$156.9 million in 2022, then skyrocketed by 108.17% to $12.8 million in 2023, then crashed by 76.17% to $3.1 million in 2024, then crashed by 430.64% to -$10.1 million in 2025.
  • Its last three reported values are -$10.1 million in Q3 2025, $2.7 million for Q2 2025, and -$918000.0 during Q1 2025.